Deep Vein Thrombosis
What's New
Last Posted: Mar 26, 2024
- Comparison of different machine learning classification models for predicting deep vein thrombosis in lower extremity fractures.
Conghui Wei et al. Sci Rep 2024 14(1) 6901 - Thromboembolic Disease in Haemophilic Patients Undergoing Major Orthopaedic Surgery: Is Thromboprophylaxis Mandatory?
Badulescu Oana Viola et al. Diagnostics (Basel, Switzerland) 2023 13(1) - Epidemiology and prevention of venous thromboembolism.
Lutsey Pamela L et al. Nature reviews. Cardiology 2022 - Machine learning predicts cancer-associated deep vein thrombosis using clinically available variables.
Jin Shuai et al. International journal of medical informatics 2022 161104733 - Non-invasive diagnosis of deep vein thrombosis from ultrasound imaging with machine learning.
Kainz Bernhard et al. NPJ digital medicine 2021 4(1) 137 - Safety of the BNT162b2 mRNA Covid-19 Vaccine in a Nationwide Setting.
Barda Noam et al. The New England journal of medicine 2021 - Short- and long-term outcomes for single-port risk-reducing salpingo-oophorectomy with and without hysterectomy for women at risk for gynecologic cancer.
Carr Caitlin E et al. International journal of gynecological cancer : official journal of the International Gynecological Cancer Society 2020 Sep - Venous Thromboembolism (Blood Clots) and Cancer
CDC, October 2019 - Pharmacogenetics of Warfarin in a Diverse Patient Population.
Mak May et al. Journal of cardiovascular pharmacology and therapeutics 2019 May 1074248419843530 - Cost Effectiveness of Genotype-Guided Warfarin Dosing in Patients with Mechanical Heart Valve Replacement Under the Fee-for-Service System.
Kim Dong-Jin et al. Applied health economics and health policy 2017 Oct 15(5) 657-667 - Thrombin generation profile in non-thrombotic factor V Leiden carriers.
Billoir Paul et al. Journal of thrombosis and thrombolysis 2019 Apr 47(3) 473-477 - CLINGEN Actionability Report for Factor V Leiden, Homozygous (also includes compound heterozygous FVL + prothrombin G20210A) - F5
ClinGen Actionability Working Group - CLINGEN Actionability Report for Factor V Leiden, Heterozygous - F5
ClinGen Actionability Working Group - CLINGEN Actionability Report for Thrombophilia due to protein C deficiency - PROC
ClinGen Actionability Working Group - CLINGEN Actionability Report for Thrombophilia due to protein S deficiency - PROS1
ClinGen Actionability Working Group - CLINGEN Actionability Report for von Willebrand Disease - VWF
ClinGen Actionability Working Group - Deep vein thrombosis during long-term surveillance of patients with liver transplantation.
Balaceanu Alice et al. Irish journal of medical science 2019 Mar - Screening to Prevent Osteoporotic Fractures: Updated Evidence Report and Systematic Review for the US Preventive Services Task Force.
Viswanathan Meera et al. JAMA 2018 Jun 319(24) 2532-2551 - The impact of real-world cardiovascular-related pharmacogenetic testing in an insured population.
Billings Jennifer et al. International journal of clinical practice 2018 May e13088 - Laboratory Testing for Activated Protein C Resistance (APCR).
Mohammed Soma et al. Methods in molecular biology (Clifton, N.J.) 2017 1646137-143
More
About HLBS-PopOmics
HLBS-PopOmics is an online, continuously updated, searchable database of published scientific literature, CDC and NIH resources, and other materials that address the translation of genomic and other precision health discoveries into improved health care and prevention related to Heart and Vascular Diseases(H), Lung Diseases(L), Blood Diseases(B), and Sleep Disorders(S)...more
Content Summary
Common HLBS Health Categories
Site Citation:
Mensah GA, Yu W, Barfield WL, Clyne M, Engelgau MM, Khoury MJ. HLBS-PopOmics: an online knowledge base to accelerate dissemination and implementation of research advances in population genomics to reduce the burden of heart, lung, blood, and sleep disorders. Genet Med. 2018 Sep 10. doi: 10.1038/s41436-018-0118-1
Disclaimer: Articles listed in the Public Health Knowledge Base are selected by Public Health Genomics Branch to provide current awareness of the literature and news. Inclusion in the update does not necessarily represent the views of the Centers for Disease Control and Prevention nor does it imply endorsement of the article's methods or findings. CDC and DHHS assume no responsibility for the factual accuracy of the items presented. The selection, omission, or content of items does not imply any endorsement or other position taken by CDC or DHHS. Opinion, findings and conclusions expressed by the original authors of items included in the update, or persons quoted therein, are strictly their own and are in no way meant to represent the opinion or views of CDC or DHHS. References to publications, news sources, and non-CDC Websites are provided solely for informational purposes and do not imply endorsement by CDC or DHHS.
- Page last reviewed:Feb 1, 2024
- Page last updated:May 07, 2024
- Content source: